Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lack of Dynamin Protein Prevents Cell Division in Toxoplasma Gondii

By LabMedica International staff writers
Posted on 24 Feb 2009
A team of molecular biologists and parasitologists working with the protozoan parasite Toxoplasma gondii has identified a protein critically involved in the process of cell division that may represent a promising drug target.

Toxoplasma belongs to a group of parasites, including the malaria parasites, which contain apicoplasts, relict nonphotosynthetic plastids found in all protozoan parasites belonging to the phylum Apicocomplexa. More...
Apicoplasts are essential for parasite growth and must correctly divide and segregate into daughter cells upon cytokinesis. Apicoplast division depends on association with the mitotic spindle, although little is known about the molecular machinery involved in this process.

To study the T. gondii apocopate, investigators from the University of Georgia (Athens, USA) genetically engineered a strain of the parasite to lack the gene for the dynamin protein DrpA. Dynamins are GTP (guanine triphosphate)ase enzymes responsible for endocytosis in eukaryotic cells. They are principally involved in the separation of newly formed vesicles from the membrane of one cellular compartment and their targeting to, and fusion with, another compartment, both at the cell surface as well as at the Golgi apparatus. Dynamins also play a role in many processes including division of organelles, cytokinesis, and microbial pathogen resistance.

Results published in the February 12, 2009, online edition of the journal Current Biology revealed that apicoplast replication was disrupted in the parasites lacking DrpA protein. Their apicoplasts could not pinch into daughter organelles, and the failure to reproduce the apicoplast caused the death of the parasite.

"The apicoplast is essential for parasitic growth and must correctly divide for the organism to stay alive,” said senior author Dr. Boris Striepen, professor of cell biology at the University of Georgia. "Understanding more of how it works is crucial to progress in understanding how these disease processes evolve.”

Related Links:
University of Georgia



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.